Abstract
Silymarin is the standardized extract from Silybum marianum which consists mainly of flavonoids and polyphenols. It is highly regarded for its hepatoprotective ability. Silybin B is a flavonolignan and one of the active components of silymarin. The content of silybin B in various parts of S. marianum was analyzed by HPLC-UV. Results show that the extract of seeds contain the highest amount of silybin B (7.434 mg/g DW). The petioles of S. marianum showed a low content of silybin B. This study revealed that seeds of S. marianum contain high amount of silybin B and could be a good source of the compound.
References
(1). Elwekeel A.., Elfishawy A.., AbouZid S. J.Med. Plants Res. 2013. 7:1665–1669.
(2). AbouZid S. F.., Chen S. N.., Pauli G. F.Ind. Crops Prod. 2016. 83:729–737.
(3). Abenavoli L.., Capasso R.., Milic N.., Capasso F.Phytother. Res. 2010. 24:1423–1432. . ê.
(4). K en V.., Walterová D.Biomed. Pap. Med. Fac. Univ. Palacky r Olomouc Czech Repub. 2005. 149:29–41. . ê ê ê.
(5). Kvasni ka F.., Bíba B.., Šev ík R.., Vold ich M.., Krátká J. J.c c Chromatogr. A. 2003. 990:239–245. . ê r Chromatogr. A. 2003 990.
(6). Saller R.., Meier R.., Brignoli R.Drugs. 2001. 61:2035–2063.
(7). Hwang I. -S.., Han E. -J.., Bak J. -S.., Kim J. -G.., Chough N.J. Nat. Prod. Sci. 2006. 12:166–173.
(8). Kim N. C.., Graf T. N.., Sparacino C. M.., Wani M. C.., Wall M. E.Org. Biomol. Chem. 2003. 1:1684–1689.
(9). Shaker E.., Mahmoud H.., Mnaa S.Food Chem. Toxicol. 2010. 48:803–806.
(10). Tamayo C.., Diamond S.Integr. Cancer Ther. 2007. 6:146–157.
(11). Csupor D.., Csorba A.., Hohmann J. J.Pharm. Biomed. Anal. 2016. 130:301–317.
(12). Loguercio C.., Festi D.World J. Gastroenterol. 2011. 17:2288–2301.
(13). Trouillas P.., Marsal P.., Svobodová A.., Vostálová J.., Gažák R.., ê Hrbác J.., Sedmera P.., K en V.., Lazzaroni R.., Duroux J. L.., Walterová r D. J.Phys. Chem. A. 2008. 112:1054–1063.
(14). Trappoliere M.., Caligiuri A.., Schmid M.., Bertolani C.., Failli P.., Vizzutti F.., Novo E.., di Manzano C.., Marra F.., Loguercio C.., Pinzani M. J.Hepatol. 2009. 50:1102–1111.
(15). Scambia G.., De Vincenzo R.., Ranelletti P. O.., Panici P. B.., Ferrandina G.., D'Agostino G.., Fattorossi A.., Bombardelli E.., Mancuso S.Eur. J. Cancer. 1996. 32:877–882.
(16). Tyagi A.., Bhatia N.., Condon M. S.., Bosland M. C.., Agarwal C.., Agarwal R.Prostate. 2002. 53:211–217.
(17). Zheng D.., Wang Y.., Zhang D.., Liu Z.., Duan C.., Jia L.., Wang F.., Liu Y.., Liu G.., Hao L.., Zhang Q.Cancer Lett. 2011. 307:158–164.
(18). Lee D. G.., Kim H. K.., Park Y.., Park S. C.., Woo E. R.., Jeong H. G.., Hahm K. S.Arch. Pharm. Res. 2003. 26:597–600.
(19). Cappelletti E. M.., Caniato R.Herba Hung. 1984. 23:53–66.